Crossmark

CD5: from antiquated T cell marker to immunotherapy’s new hope

Crossref DOI link: https://doi.org/10.1038/s41392-023-01494-5

Published Online: 2023-05-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Schwarz, Sandra https://orcid.org/0000-0002-8112-4392
Linnebacher, Michael https://orcid.org/0000-0001-8054-1402
License Information

Text and Data Mining valid from 2023-05-25

Version of Record valid from 2023-05-25
More Information

Article History

Received: 11 April 2023

Revised: 28 April 2023

Accepted: 7 May 2023

First Online: 25 May 2023

Competing interests

: The authors declare no competing interests.